[Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].
D000328:Adult; D000368:Aged; D001645:Biguanides / Q000627:therapeutic use; D001786:Blood Glucose; D002986:Clinical Trials as Topic; D003510:Cyclohexanes / Q000009:adverse effects / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use*
D001645:Biguanides; D001786:Blood Glucose; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D011719:Pyrazines; D013453:Sulfonylurea Compounds
Valutazione di una nuova sulfanilurea, la glipizide, nel trattamento del diabete mellito.